E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/3/2009 in the Prospect News Convertibles Daily.

PharmaNet to retire $144 million convertibles with equity commitment

By Susanna Moon

Chicago, Feb. 3 - PharmaNet Development Group, Inc. said it will retire $144 million principal amount of its outstanding convertible notes.

The deal will be financed by a $250 million equity commitment.

PharmaNet is a drug development services company based in Princeton, N.J.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.